Published in J Clin Immunol on March 09, 2011
The adaptive immune response in celiac disease. Semin Immunopathol (2012) 0.97
Transglutaminase 2-specific autoantibodies in celiac disease target clustered, N-terminal epitopes not displayed on the surface of cells. J Immunol (2013) 0.91
Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterol J (2015) 0.91
Open conformation tissue transglutaminase testing for celiac dietary assessment. Dig Liver Dis (2012) 0.77
Is the Diagnosis of Celiac Disease Possible Without Intestinal Biopsy? Balkan Med J (2017) 0.75
Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med (1997) 7.42
Sensitivity of antiendomysium and antigliadin antibodies in untreated celiac disease: disappointing in clinical practice. Am J Gastroenterol (1999) 3.84
Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet (2000) 3.47
Transglutaminases: nature's biological glues. Biochem J (2002) 3.42
Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology (1998) 3.22
Celiac disease: from pathogenesis to novel therapies. Gastroenterology (2009) 2.84
Transglutaminase 2 undergoes a large conformational change upon activation. PLoS Biol (2007) 2.53
Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol (2005) 2.49
Long-term follow-up of 61 coeliac patients diagnosed in childhood: evolution toward latency is possible on a normal diet. Gut (2007) 2.34
Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA (2010) 1.99
Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology (2008) 1.93
Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis. J Clin Gastroenterol (2010) 1.70
Extracellular transglutaminase 2 is catalytically inactive, but is transiently activated upon tissue injury. PLoS One (2008) 1.67
When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol (2001) 1.60
Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut (2006) 1.51
Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther (2006) 1.39
IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol (2002) 1.24
Comparison of anti-transglutaminase ELISAs and an anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study. Clin Chem (2002) 1.24
Diagnostic accuracy of ten second-generation (human) tissue transglutaminase antibody assays in celiac disease. Clin Chem (2004) 1.17
Correlation of duodenal histology with tissue transglutaminase and endomysial antibody levels in pediatric celiac disease. Clin Gastroenterol Hepatol (2007) 1.13
Comparison of a novel whole blood transglutaminase-based ELISA with a whole blood rapid antibody test and established conventional serological celiac disease assays. J Pediatr Gastroenterol Nutr (2008) 1.04
Performance of serology assays for diagnosing celiac disease in a clinical setting. Clin Vaccine Immunol (2009) 0.95
Anti-tissue transglutaminase antibodies in the follow-up of adult coeliac disease. Aliment Pharmacol Ther (2009) 0.92
Toward a checklist for reporting of studies of diagnostic accuracy of medical tests. Clin Chem (2000) 0.81
Follow-up of adult celiac patients: which noninvasive test reflects mucosal status most reliably?1. Endoscopy (2009) 0.80
Biochemical and immuno-pathological aspects of tissue transglutaminase in coeliac disease. Autoimmunity (2003) 0.79
Serologic tests for celiac disease. Gastroenterology (2003) 0.77
Diagnostic testing for celiac disease. JAMA (2010) 0.75
Prevalence of Celiac disease among children in Finland. N Engl J Med (2003) 7.27
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med (2012) 3.35
HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease. Hum Immunol (2003) 3.17
Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology (2002) 2.99
The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann Med (2010) 2.84
Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study. Eur J Gastroenterol Hepatol (2005) 2.49
Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest (2005) 2.41
Celiac disease without villous atrophy in children: a prospective study. J Pediatr (2010) 2.24
Burden of illness in screen-detected children with celiac disease and their families. J Pediatr Gastroenterol Nutr (2012) 2.20
The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: a follow-up of 20 years. J Crohns Colitis (2013) 2.03
Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology (2008) 1.93
European multi-centre study on coeliac disease and non-Hodgkin lymphoma. Eur J Gastroenterol Hepatol (2006) 1.92
Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol (2003) 1.92
Design, synthesis, and evaluation of gluten peptide analogs as selective inhibitors of human tissue transglutaminase. Chem Biol (2003) 1.81
Endocrinological disorders and celiac disease. Endocr Rev (2002) 1.71
Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol (2009) 1.65
Utility of the new ESPGHAN criteria for the diagnosis of celiac disease in at-risk groups. J Pediatr Gastroenterol Nutr (2012) 1.60
Celiac disease and HLA DQ in patients with IgA nephropathy. Am J Gastroenterol (2002) 1.60
Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. Scand J Gastroenterol (2005) 1.58
HLA-DQ typing in the diagnosis of celiac disease. Am J Gastroenterol (2002) 1.58
Oats can diversify a gluten-free diet in celiac disease and dermatitis herpetiformis. J Am Diet Assoc (2004) 1.58
Factors associated with long diagnostic delay in celiac disease. Scand J Gastroenterol (2014) 1.54
Mortality excess in individuals with elevated IgA anti-transglutaminase antibodies: the KORA/MONICA Augsburg cohort study 1989-1998. Eur J Epidemiol (2006) 1.51
Secretor genotype (FUT2 gene) is strongly associated with the composition of Bifidobacteria in the human intestine. PLoS One (2011) 1.49
Early microbial markers of celiac disease. J Clin Gastroenterol (2014) 1.48
Global gene expression profile of human cord blood-derived CD133+ cells. Stem Cells (2005) 1.42
Donor-recipient mismatch for common gene deletion polymorphisms in graft-versus-host disease. Nat Genet (2009) 1.40
Lower economic status and inferior hygienic environment may protect against celiac disease. Ann Med (2008) 1.39
Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase. J Pediatr Gastroenterol Nutr (2010) 1.34
AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype. J Clin Endocrinol Metab (2002) 1.33
Association of IFIH1 and other autoimmunity risk alleles with selective IgA deficiency. Nat Genet (2010) 1.32
Coeliac disease, autoimmune diseases and gluten exposure. Scand J Gastroenterol (2005) 1.29
Gluten-free diet and quality of life in patients with screen-detected celiac disease. Eff Clin Pract (2002) 1.28
Transcription factors GATA-4 and GATA-6 in normal and neoplastic human gastrointestinal mucosa. BMC Gastroenterol (2008) 1.28
IgA-class transglutaminase antibodies in evaluating the efficacy of gluten-free diet in coeliac disease. Eur J Gastroenterol Hepatol (2002) 1.24
Association of IL23R, TNFRSF1A, and HLA-DRB1*0103 allele variants with inflammatory bowel disease phenotypes in the Finnish population. Inflamm Bowel Dis (2008) 1.20
Human leukocyte antigen-B8-DR3 is a more important risk factor for severe Puumala hantavirus infection than the tumor necrosis factor-alpha(-308) G/A polymorphism. J Infect Dis (2002) 1.18
Functional network reconstruction reveals somatic stemness genetic maps and dedifferentiation-like transcriptome reprogramming induced by GATA2. Stem Cells (2008) 1.16
Validation of morphometric analyses of small-intestinal biopsy readouts in celiac disease. PLoS One (2013) 1.13
Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol (2009) 1.11
Association of HLA-DRB1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population--a candidate gene approach. Int J Cancer (2009) 1.11
Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol (2007) 1.09
The duodenal microbiota composition of adult celiac disease patients is associated with the clinical manifestation of the disease. Inflamm Bowel Dis (2013) 1.08